Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 2
2008 9
2009 6
2010 13
2011 8
2012 5
2013 5
2014 6
2015 5
2016 5
2017 6
2018 1
2019 9
2020 10
2021 15
2022 8
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis.
Raschi E, Salvo F, Bate A, De Ponti F, Poluzzi E, Tuccori M, van Puijenbroek E, Joshi N, Khouri C. Raschi E, et al. Among authors: tuccori m. Drug Saf. 2024 Mar 18. doi: 10.1007/s40264-024-01419-3. Online ahead of print. Drug Saf. 2024. PMID: 38498258 No abstract available.
Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project.
Ingrasciotta Y, Spini A, L'Abbate L, Fiore ES, Carollo M, Ientile V, Isgrò V, Cavazzana A, Biasi V, Rossi P, Ejlli L, Belleudi V, Poggi F, Sapigni E, Puccini A, Ancona D, Stella P, Pollina Addario S, Allotta A, Leoni O, Zanforlini M, Tuccori M, Gini R, Trifirò G. Ingrasciotta Y, et al. Among authors: tuccori m. Pharmacol Res. 2024 Feb;200:107074. doi: 10.1016/j.phrs.2024.107074. Epub 2024 Jan 15. Pharmacol Res. 2024. PMID: 38232909 Free article.
Corrigendum to "Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation" [Clin Microbiol Infect 28 (12) (2022 Dec) 1657-1658].
Antonelli G, Focosi D, Turriziani O, Tuccori M, Brandi R, Fillo S, Ajassa C, Lista F, Mastroianni CM. Antonelli G, et al. Among authors: tuccori m. Clin Microbiol Infect. 2024 Mar;30(3):408. doi: 10.1016/j.cmi.2023.12.014. Epub 2023 Dec 14. Clin Microbiol Infect. 2024. PMID: 38103639 Free PMC article. No abstract available.
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.
Convertino I, Cazzato M, Tillati S, Giometto S, Gini R, Valdiserra G, Cappello E, Ferraro S, Bonaso M, Bartolini C, Paoletti O, Lorenzoni V, Trieste L, Filippi M, Turchetti G, Cristofano M, Blandizzi C, Mosca M, Lucenteforte E, Tuccori M. Convertino I, et al. Among authors: tuccori m. Front Pharmacol. 2023 Sep 25;14:1244486. doi: 10.3389/fphar.2023.1244486. eCollection 2023. Front Pharmacol. 2023. PMID: 37818193 Free PMC article.
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison.
Machado FLDS, Cañás M, Doubova SV, Urtasun MA, Marín GH, Osorio-de-Castro CGS, Albuquerque FC, Ribeiro TB, Pont L, Crisóstomo Landeros J, Roldán Saelzer J, Sepúlveda Viveros D, Acosta A, Machado Beltrán MA, Gordillo Alas LI, Orellana Tablas LA, Benko R, Convertino I, Bonaso M, Tuccori M, Kirchmayer U, Contreras Sánchez SE, Rodríguez-Tanta LY, Gutierrez Aures Y, Lin B, Alipour-Haris G, Eworuke E, Lopes LC. Machado FLDS, et al. Among authors: tuccori m. Regul Toxicol Pharmacol. 2023 Oct;144:105485. doi: 10.1016/j.yrtph.2023.105485. Epub 2023 Sep 1. Regul Toxicol Pharmacol. 2023. PMID: 37659711
115 results